|
1. Why pharmacy integration is no longer optional Full story
2. CVS begins accepting TrumpRx discount cards nationwide Full story
3. See how top health systems are strengthening pharmacy supply chains and preparing for what comes next: here.
4. FDA fast-tracks U of Wisconsin cell therapy for Sjögren's symptom Full story
5. FDA rejects Regenxbio's rare disease gene therapy Full story
6. Using genetic data to guide medication choices can improve efficacy and reduce adverse effects. See why pharmacogenomics matters. Learn more
7. TrumpRx taps GoodRx for discounted drug pricing Full story
8. Court upholds Louisiana's 340B discount law Full story
9. The 74 hospitals to earn Magnet's top honor Full story
10. CVS Health 2025 profit falls short of $1.8B Full story
11. Novo Nordisk GLP-1 sales surge: 7 things to know Full story
12. Drug shortages, margin pressure and 340B scrutiny are colliding. Learn how leaders can respond here.
Becker's Learning Opportunities
13. Labor strategy fails without housing strategy. Why CEOs are acting now here.
14. Cardiac device integration gaps are costly. How a USF clinic fixed them + scaled monitoring here.
15. Mid-revenue cycle gaps cost hospitals millions. Learn where here.
16. Interested in more? See Becker’s full lineup of
webinars and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
